Concentration-time-effect modeling of agent combinations

药剂组合的浓度-时间-效应模型

基本信息

项目摘要

DESCRIPTION: The overall aim of the project is to further develop and validate a new comprehensive concentration-time-effect modeling paradigm, created during the last 3-year funding period of RRI 0742 for single agents and for high order combinations of agents, for anticancer chemotherapy and other pharmacological applications, with new emphases on the measurement of individual cell responses, cell response heterogeneity quantification, assays of molecular targets, and the use of molecularly-targeted agents. The final modeling paradigm which will result from this project is intended to bridge the gap between traditional pharmacometrics and the new era of molecular bioinformatics. The Specific Aims include: 1. The validity and utility of a new mathematical! . statistical modeling paradigm, derived to describe concentration-time-effect phenomena for single agents and 2-agent, 3-agent, 4-agent and 5-agent combinations, will be investigated in a well-characterized, simple in vitro antiproliferation assay, the total growth assay (TGA). Specific combinations of anticancer agents will include both classic clinically-used agents and novel molecularly-targeted signal transduction inhibitors. 2. A multiplex time lapse video system (mpTLV) with automated image analysis tracking of cells in the digital video record will be developed, to allow detailed analysis of cellular response to anticancer agents to be done rapidly. 3. Mathematical/statistical models of proliferative and cell death response to single anticancer agents and combinations of agents, that include individual cell responses of growth delay, growth slow-down, growth arrest, apoptosis, and other forms of cell death, will be derived to provide a more detailed knowledge of cellular response. 4. D-optimal statistical design methodology for the Hill concentration-effect model developed under RR1 0742 for single agent concentration-effect studies, will be further developed for applications to the complex studies in Specific Aims #1 and #3. 5. An Internet Web site will be created to give the scientific public assess to: the rich data sets generated; the data analysis and modeling tools developed; results; and a discussion room for the general topic of concentration-time-effect and synergy modeling.
描述:该项目的总体目标是进一步开发和验证

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine.
  • DOI:
  • 发表时间:
    1990-09
  • 期刊:
  • 影响因子:
    11.2
  • 作者:
    William R. Greco;Hyoung Sook Park;Y. Rustum
  • 通讯作者:
    William R. Greco;Hyoung Sook Park;Y. Rustum
Quantitation of folic acid enhancement of antifolate synergism.
叶酸定量增强抗叶酸协同作用。
  • DOI:
  • 发表时间:
    1992
  • 期刊:
  • 影响因子:
    11.2
  • 作者:
    Gaumont,Y;Kisliuk,RL;Parsons,JC;Greco,WR
  • 通讯作者:
    Greco,WR
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WILLIAM Robert GRECO其他文献

WILLIAM Robert GRECO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WILLIAM Robert GRECO', 18)}}的其他基金

Core C
核心C
  • 批准号:
    6748005
  • 财政年份:
    2003
  • 资助金额:
    $ 39.18万
  • 项目类别:
CORE--BIOMATHEMATICS
核心--生物数学
  • 批准号:
    6300405
  • 财政年份:
    2000
  • 资助金额:
    $ 39.18万
  • 项目类别:
CORE--BIOMATHEMATICS
核心--生物数学
  • 批准号:
    6102736
  • 财政年份:
    1999
  • 资助金额:
    $ 39.18万
  • 项目类别:
CORE--BIOMATHEMATICS/BIOSTATISTICS RESOURCE
核心--生物数学/生物统计资源
  • 批准号:
    6101713
  • 财政年份:
    1999
  • 资助金额:
    $ 39.18万
  • 项目类别:
CORE--BIOMATHEMATICS
核心--生物数学
  • 批准号:
    6269524
  • 财政年份:
    1998
  • 资助金额:
    $ 39.18万
  • 项目类别:
CORE--BIOMATHEMATICS/BIOSTATISTICS RESOURCE
核心--生物数学/生物统计资源
  • 批准号:
    6268846
  • 财政年份:
    1998
  • 资助金额:
    $ 39.18万
  • 项目类别:
CORE--BIOMATHEMATICS/BIOSTATISTICS RESOURCE
核心--生物数学/生物统计资源
  • 批准号:
    6236251
  • 财政年份:
    1997
  • 资助金额:
    $ 39.18万
  • 项目类别:
ASSESSMENT OF THE NATURE INTENSITY & BASIS OF SYNERGISM
自然强度评估
  • 批准号:
    2040192
  • 财政年份:
    1989
  • 资助金额:
    $ 39.18万
  • 项目类别:
DETERMINATION OF SYNERGISM, ADDITIVITY & ANTAGONISM
协同性、相加性的测定
  • 批准号:
    3190100
  • 财政年份:
    1989
  • 资助金额:
    $ 39.18万
  • 项目类别:
ASSESSMENT OF THE NATURE INTENSITY & BASIS OF SYNERGISM
自然强度评估
  • 批准号:
    2901473
  • 财政年份:
    1989
  • 资助金额:
    $ 39.18万
  • 项目类别:

相似海外基金

The analysis of proteinuria caused by antineoplastics and the preventative effects with antihypertensive medications using the Japanese medical database
利用日本医学数据库分析抗肿瘤药物引起的蛋白尿及抗高血压药物的预防效果
  • 批准号:
    21K17258
  • 财政年份:
    2021
  • 资助金额:
    $ 39.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Expediting Drug Development by Profiling Novel Antineoplastics by Mass Spectrometry-based Biomarker Profiling
通过基于质谱的生物标志物分析来分析新型抗肿瘤药物,加速药物开发
  • 批准号:
    499958-2016
  • 财政年份:
    2016
  • 资助金额:
    $ 39.18万
  • 项目类别:
    Engage Grants Program
Combinatorial Peptidomimetics as Antineoplastics
作为抗肿瘤药的组合肽模拟物
  • 批准号:
    6623455
  • 财政年份:
    2002
  • 资助金额:
    $ 39.18万
  • 项目类别:
Combinatorial Peptidomimetics as Antineoplastics
作为抗肿瘤药的组合肽模拟物
  • 批准号:
    6465958
  • 财政年份:
    2002
  • 资助金额:
    $ 39.18万
  • 项目类别:
Novel Nanoparticle Delivery System for Antineoplastics
新型抗肿瘤纳米颗粒输送系统
  • 批准号:
    6483914
  • 财政年份:
    2002
  • 资助金额:
    $ 39.18万
  • 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
  • 批准号:
    6124630
  • 财政年份:
    1998
  • 资助金额:
    $ 39.18万
  • 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
  • 批准号:
    6329037
  • 财政年份:
    1998
  • 资助金额:
    $ 39.18万
  • 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
  • 批准号:
    2747737
  • 财政年份:
    1998
  • 资助金额:
    $ 39.18万
  • 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
  • 批准号:
    3459680
  • 财政年份:
    1990
  • 资助金额:
    $ 39.18万
  • 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
  • 批准号:
    3459678
  • 财政年份:
    1990
  • 资助金额:
    $ 39.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了